Skip to main content

Find Clinical Trials

Home
Conditions
Ovarian Neoplasms

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

2,296 public trials 506 recruiting studies

Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Completed

Enzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GREKO III Study

NCT03464201

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Hospital de Mar Barcelona, Spain

Hospital Reina Sofia Córdoba, Spain

Hospital Madrid Sanchinarro (CIOCC) Madrid, Spain

Hospital Universitario La Paz Madrid, Spain

View Trial Details

Completed

Effectiveness and Safety of Niraparib as First-line Maintenance Therapy for Ovarian Cancer: a Real-world Study

NCT05734911

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations: Zhongda hospital Nanjing, China

View Trial Details

Completed

A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT03038100

Conditions: Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +21 more
Locations: St. Joseph'S Hospital & Medical Center Phoenix, Arizona, United States

Arizona Oncology Associates, PC - HAL Scottsdale, Arizona, United States

Arizona Oncology - HOPE Wilmot Tucson, Arizona, United States

Moores Cancer Center at UC San Diego Health La Jolla, California, United States

View all 268 locations

View Trial Details

Completed

Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian Cancer

NCT03639246

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Arizona Oncology Phoenix, Arizona, United States

Arizona Oncology Associates Tucson, Arizona, United States

Kaiser Permanente Oakland Oakland, California, United States

Kaiser Permanente Roseville Roseville, California, United States

View all 16 locations

View Trial Details

Completed

Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125

NCT03004391

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Department of Oncology, Vejle Hospital Vejle, Denmark

View Trial Details

Completed

Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies

NCT02025985

Conditions: Adnexal Diseases, Cervical Carcinoma, Endocrine Gland Neoplasms, +20 more
Locations: UZ Leuven - Universitair Ziekenhuis Leuven Leuven, Belgium

Aalborg University Hospital Aalborg, Denmark

Rigshospitalet Copenhagen, Denmark

Herlev Hospital Herlev, Denmark

View Trial Details

Completed

Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer

NCT02973750

Conditions: Adnexal Diseases, Digestive System Diseases, Endocrine Gland Neoplasms, +19 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Irinotecan Liposome and Bevacizumab for the Treatment of Platinum Resistant, Recurrent, or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT04753216

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +23 more
Locations: Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

NCT04430842

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +129 more
Locations: St George Private Hospital Kogarah, New South Wales, Australia

Sydney Southwest Private Hospital Liverpool, New South Wales, Australia

View Trial Details

Completed

A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)

NCT03398655

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations: UAB Division of GYN Oncology Birmingham, Alabama, United States

Western Regional Medical Center Goodyear, Arizona, United States

Arizona Oncology Associates, PC - HAL - USO Phoenix, Arizona, United States

Arizona Oncology Associates, PC - HAL - USO Tempe, Arizona, United States

View all 94 locations

View Trial Details